new BindingDB logo
myBDB logout

BDBM50121465 5-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-naphthalen-2-ylmethyl)-furan-2-carboxylic acid {4-[(2-{[(S)-1-(tetrahydro-furan-2-yl)methyl]-amino}-pyrimidin-4-ylamino)-methyl]-cyclohexylmethyl}-amide::CHEMBL121535

SMILES: Cc1cc2c(cc1Cc1ccc(o1)C(=O)NC[C@H]1CC[C@H](CNc3ccnc(NC[C@@H]4CCCO4)n3)CC1)C(C)(C)CCC2(C)C

InChI Key: InChIKey=GKXQDVVMFQLVAT-VWYPKUQYSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50121465   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Gonadotropin releasing hormone 1 (GnRHR1)


(Homo sapiens (Human))
BDBM50121465
PNG
(5-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-naphth...)
Show SMILES Cc1cc2c(cc1Cc1ccc(o1)C(=O)NC[C@H]1CC[C@H](CNc3ccnc(NC[C@@H]4CCCO4)n3)CC1)C(C)(C)CCC2(C)C |wU:20.22,30.31,wD:17.18,(1.39,3.28,;.04,4,;-1.33,3.28,;-2.7,4,;-2.7,5.43,;-1.34,6.15,;.03,5.44,;1.38,6.17,;2.77,5.46,;2.76,4.01,;5.48,4,;5.48,5.44,;4.13,6.17,;6.86,6.17,;6.87,7.61,;8.23,5.43,;9.59,6.14,;10.96,5.43,;10.94,3.99,;12.31,3.26,;13.68,3.99,;15.17,3.09,;16.69,3.92,;18.17,3.02,;18.17,1.58,;19.54,.86,;20.9,1.59,;20.9,3.02,;22.38,3.92,;23.92,3.09,;25.4,3.99,;26.63,2.78,;28.74,4.91,;27.49,6.12,;25.82,5.67,;19.54,3.75,;13.68,5.43,;12.31,6.14,;-4.07,6.17,;-5.43,6.88,;-2.7,6.89,;-5.41,5.43,;-5.41,3.99,;-4.07,3.28,;-2.7,2.57,;-5.43,2.57,)|
Show InChI InChI=1S/C38H53N5O3/c1-25-19-31-32(38(4,5)16-15-37(31,2)3)21-28(25)20-29-12-13-33(46-29)35(44)41-23-27-10-8-26(9-11-27)22-40-34-14-17-39-36(43-34)42-24-30-7-6-18-45-30/h12-14,17,19,21,26-27,30H,6-11,15-16,18,20,22-24H2,1-5H3,(H,41,44)(H2,39,40,42,43)/t26-,27-,30-/m0/s1
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents

PubMed
28n/an/an/an/an/an/an/an/a



Pfizer Global Research and Development-La Jolla/Agouron Pharmaceuticals

Curated by ChEMBL


Assay Description
In vitro binding affinity towards human gonadotropin-releasing hormone receptor


Bioorg Med Chem Lett 12: 3635-9 (2002)


BindingDB Entry DOI: 10.7270/Q2XK8DXZ
More data for this
Ligand-Target Pair
Gonadotropin-releasing hormone receptor


(Rattus norvegicus)
BDBM50121465
PNG
(5-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-naphth...)
Show SMILES Cc1cc2c(cc1Cc1ccc(o1)C(=O)NC[C@H]1CC[C@H](CNc3ccnc(NC[C@@H]4CCCO4)n3)CC1)C(C)(C)CCC2(C)C |wU:20.22,30.31,wD:17.18,(1.39,3.28,;.04,4,;-1.33,3.28,;-2.7,4,;-2.7,5.43,;-1.34,6.15,;.03,5.44,;1.38,6.17,;2.77,5.46,;2.76,4.01,;5.48,4,;5.48,5.44,;4.13,6.17,;6.86,6.17,;6.87,7.61,;8.23,5.43,;9.59,6.14,;10.96,5.43,;10.94,3.99,;12.31,3.26,;13.68,3.99,;15.17,3.09,;16.69,3.92,;18.17,3.02,;18.17,1.58,;19.54,.86,;20.9,1.59,;20.9,3.02,;22.38,3.92,;23.92,3.09,;25.4,3.99,;26.63,2.78,;28.74,4.91,;27.49,6.12,;25.82,5.67,;19.54,3.75,;13.68,5.43,;12.31,6.14,;-4.07,6.17,;-5.43,6.88,;-2.7,6.89,;-5.41,5.43,;-5.41,3.99,;-4.07,3.28,;-2.7,2.57,;-5.43,2.57,)|
Show InChI InChI=1S/C38H53N5O3/c1-25-19-31-32(38(4,5)16-15-37(31,2)3)21-28(25)20-29-12-13-33(46-29)35(44)41-23-27-10-8-26(9-11-27)22-40-34-14-17-39-36(43-34)42-24-30-7-6-18-45-30/h12-14,17,19,21,26-27,30H,6-11,15-16,18,20,22-24H2,1-5H3,(H,41,44)(H2,39,40,42,43)/t26-,27-,30-/m0/s1
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents

PubMed
370n/an/an/an/an/an/an/an/a



Pfizer Global Research and Development-La Jolla/Agouron Pharmaceuticals

Curated by ChEMBL


Assay Description
In vitro binding affinity towards rat gonadotropin-releasing hormone receptor


Bioorg Med Chem Lett 12: 3635-9 (2002)


BindingDB Entry DOI: 10.7270/Q2XK8DXZ
More data for this
Ligand-Target Pair